Background <p>Aesthetic body surgeries such as liposuction, abdominoplasty, gluteoplasty, and breast augmentation have seen a global rise. However, the growing popularity of these procedures has led to increased reports of postoperative complications and medico-legal disputes.</p> Objective <p>To systematically review complications and litigation outcomes associated with aesthetic body surgeries and identify the most common risk factors contributing to legal claims.</p> Methods <p>A systematic review was conducted in accordance with PRISMA guidelines (registration on PROSPERO ID: CRD420251043585). Forty-one studies published since between 2020 and 2025 were included. Complications, allegations, and legal outcomes were extracted and analysed. Risk of bias was assessed using JBI and ROBINS-I tools.</p> Results <p>Infection (48.7%), fat embolism (26.8%), and hematoma (21.9%) were the most frequent complications. Gluteal fat grafting had the highest mortality and legal risk, with a 7.77% incidence of fat embolism. Inadequate informed consent was a leading allegation in over 50% of cases. Claims most often resulted in dismissal (45-76%), but 20-40% led to settlements or plaintiff verdicts, especially in cases of severe complications such as embolism or disfigurement. The pooled average of favourable verdicts for surgeons was 54.3% (95% CI: 49-59%). Publication bias was suggested by asymmetrical funnel plot distribution and high heterogeneity (I<sup>2</sup> &gt; 90%).</p> Conclusion <p>Medico-legal disputes in aesthetic body surgery commonly arise from preventable complications, especially when informed consent is inadequate or postoperative care is substandard. Standardised consent process, improved documentation, procedure-specific risk communication, and regulation of outpatient practices are critical to reducing litigation risk.</p> Level of Evidence III <p>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Litigation and Complications Arising from Aesthetic Body Surgery: A Systematic Review

  • Saule A. Mussabekova,
  • Yuliya Menchisheva,
  • Álvaro Varela Morillas

摘要

Background

Aesthetic body surgeries such as liposuction, abdominoplasty, gluteoplasty, and breast augmentation have seen a global rise. However, the growing popularity of these procedures has led to increased reports of postoperative complications and medico-legal disputes.

Objective

To systematically review complications and litigation outcomes associated with aesthetic body surgeries and identify the most common risk factors contributing to legal claims.

Methods

A systematic review was conducted in accordance with PRISMA guidelines (registration on PROSPERO ID: CRD420251043585). Forty-one studies published since between 2020 and 2025 were included. Complications, allegations, and legal outcomes were extracted and analysed. Risk of bias was assessed using JBI and ROBINS-I tools.

Results

Infection (48.7%), fat embolism (26.8%), and hematoma (21.9%) were the most frequent complications. Gluteal fat grafting had the highest mortality and legal risk, with a 7.77% incidence of fat embolism. Inadequate informed consent was a leading allegation in over 50% of cases. Claims most often resulted in dismissal (45-76%), but 20-40% led to settlements or plaintiff verdicts, especially in cases of severe complications such as embolism or disfigurement. The pooled average of favourable verdicts for surgeons was 54.3% (95% CI: 49-59%). Publication bias was suggested by asymmetrical funnel plot distribution and high heterogeneity (I2 > 90%).

Conclusion

Medico-legal disputes in aesthetic body surgery commonly arise from preventable complications, especially when informed consent is inadequate or postoperative care is substandard. Standardised consent process, improved documentation, procedure-specific risk communication, and regulation of outpatient practices are critical to reducing litigation risk.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.